Evidence map›Paper›PMID 27225188›Full record

ArticleMolecular genetics and genomics : MGG2016

Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer.

Jing Han, Wen Zhou, Meiqun Jia, Juan Wen, Jie Jiang, Jufang Shi, Kai Zhang, Hongxia Ma, Jibin Liu, Jiansong Ren and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The Role of the PAX Genes in Renal Cell Carcinoma.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jing HanJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China.
Wen ZhouJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China.
Meiqun JiaJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China.
Juan WenJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China.
Jie JiangJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China.
Jufang ShiNational Office for Cancer Prevention and Control, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, No. 17 Panjiayuannanli, Chaoyang District, Beijing, China.
Kai ZhangDepartment of Cancer Prevention, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Hongxia MaJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China.
Jibin LiuDepartment of Hepatobiliary Surgery, Nantong Tumor Hospital, Nantong, China.
Jiansong RenNational Office for Cancer Prevention and Control, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, No. 17 Panjiayuannanli, Chaoyang District, Beijing, China.
Min DaiNational Office for Cancer Prevention and Control, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, No. 17 Panjiayuannanli, Chaoyang District, Beijing, China.
Zhibin HuJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China.
Dong HangJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China. hangdong@njmu.edu.cn.
Ni LiNational Office for Cancer Prevention and Control, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, No. 17 Panjiayuannanli, Chaoyang District, Beijing, China. lini1240@hotmail.com.
Hongbing ShenJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Department of Epidemiology and Biostatistics, School of Public Health, Cancer Center, Nanjing Medical University, Nanjing, 211166, China. hbshen@njmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paired box 8 (PAX8) is a crucial nephric-lineage transcription factor, and its aberrant expression has been detected in various types of cancer including Müllerian carcinomas. PAX8 antisense RNA 1 (PAX8-AS1), a potential regulator of PAX8, contains specific single nucleotide polymorphisms (SNPs) that may represent expression quantitative trait loci (eQTLs) for PAX8. In this study, we hypothesized that these eQTLs SNPs in PAX8-AS1 may influence the risk of cervical cancer. A case-control study of 1486 cervical cancer patients and 1536 cancer-free controls was conducted to identify the associations between two eQTLs SNPs (rs4848320 and rs1110839) and cervical cancer. Logistic regression analyses revealed that variant allele T of rs4848320 (recessive model: adjusted OR = 0.61, 95 % CI = 0.38-0.97, P = 0.027) and G of rs1110839 (additive model: adjusted OR = 0.88, 95 % CI = 0.79-0.99, P = 0.032) were associated with decreased risk of cervical cancer. Moreover, the haplotype containing variant alleles of the two SNPs significantly decreased the risk of cervical cancer compared to the most frequent haplotype (adjusted OR = 0.82, 95 % CI = 0.70-0.95, P = 0.009). These findings indicate that PAX8 eQTLs SNPs may serve as novel susceptibility markers for cervical cancer.

Indexed as

Polymorphism, Single NucleotideQuantitative Trait LociCase-Control StudiesFemaleGenetic Association StudiesHaplotypesHumansLogistic ModelsPAX8 Transcription FactorRNA, Long NoncodingUterine Cervical Neoplasmslong non-coding RNA PAX8-AS1, humanPAX8 protein, humanPAX8 Transcription FactorRNA, Long NoncodingCervical cancerLncRNAPAX8PAX8-AS1Single nucleotide polymorphism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.